Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial
Source: news.google.com
Published: Jun 26, 2026 03:29
Source: news.google.com
Published: Jun 26, 2026 03:29
Related Stories
3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research simplywall.st
#Biotech HeadlinesKorea's chip fund makes first biotech bet, backing LigaChem with $323 million koreabiomed.com
#Biotech HeadlinesFIRST AID: Biotech Act deal by Christmas? Euractiv
#Biotech HeadlinesComment: A smarter approach to deliver stronger clinical trials Healthcare Today
#Clinical TrialsCity of North Vancouver, partners sign MOU to develop health innovation district CBC
#Health InnovationAfter buying Apellis for $5.6B, Biogen is cutting most of its pipeline work Endpoints News
#Biotech HeadlinesAdd Shortcut
Open this site faster like an app from your phone home screen.